Further studies into infection-driven immune activation, as a risk factor for CVD, are warranted, but guidelines for prevention of CVD in HIV-infected individuals are urgently needed and should focus on hypertension reduction and close monitoring for those starting ART at lower CD4+ T-cell counts. Here, CD4 is linked to infection.